The FDA has cleared TumorSight Risk, software that uses a patient's existing breast MRI, pathology and clinical information to estimate the chance that early HR-positive, HER2-negative breast cancer ...

Emma Halligan found connection at a free New Jersey retreat for women with cancer, which held its annual walk and 5K on Oct.

Twenty-four years after breast cancer, one survivor reflects on mammogram anxiety, the relief of clear results and the ...

Eileen Carter was told she had two to three years to live after a stage 4 breast cancer diagnosis. A second opinion changed ...

CURE ® readers have a unique opportunity each year to honor oncology nurses who have helped guide them through the cancer experience. Many thoughtful nomination essays are prepared and submitted by ...